Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CGCNASDAQ:CRONOTCMKTS:STDAFNASDAQ:TLRYNYSE:USNA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCGCCanopy Growth$1.22$1.43$0.77▼$8.65$224.32M0.756.25 million shs7.51 million shsCRONCronos Group$1.91+0.5%$1.94$1.60▼$2.54$736.65M1.041.34 million shs844,381 shsSTDAFSTADA Arzneimittel Aktiengesellschaft$110.42$110.42$75.15▼$115.00$6.88B0.38180 shsN/ATLRYTilray Brands$0.41+3.4%$0.43$0.35▼$2.15$417.09M1.8329.67 million shs17.72 million shsUSNAUSANA Health Sciences$30.58-1.8%$29.29$23.10▼$48.85$569.40M0.63139,196 shs142,093 shs10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCGCCanopy Growth0.00%-1.61%-7.22%+34.07%-81.09%CRONCronos Group0.00%+2.15%-4.04%+4.97%-18.45%STDAFSTADA Arzneimittel Aktiengesellschaft0.00%0.00%0.00%0.00%0.00%TLRYTilray Brands0.00%+11.31%-8.56%-39.06%-75.86%USNAUSANA Health Sciences0.00%+2.06%+4.09%+15.63%-31.04%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCGCCanopy Growth2.5596 of 5 stars2.53.00.00.02.10.01.3CRONCronos Group2.4726 of 5 stars0.05.00.00.02.60.02.5STDAFSTADA Arzneimittel AktiengesellschaftN/AN/AN/AN/AN/AN/AN/AN/ATLRYTilray Brands1.8637 of 5 stars3.11.00.00.03.00.01.3USNAUSANA Health Sciences3.1906 of 5 stars2.02.00.03.20.01.73.8Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCGCCanopy Growth 1.00Sell$2.0063.93% UpsideCRONCronos Group 0.00N/AN/AN/ASTDAFSTADA Arzneimittel Aktiengesellschaft 0.00N/AN/AN/ATLRYTilray Brands 2.25Hold$1.92362.52% UpsideUSNAUSANA Health Sciences 2.00Hold$36.0017.72% UpsideCurrent Analyst Ratings BreakdownLatest CGC, TLRY, STDAF, CRON, and USNA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/30/2025CGCCanopy GrowthPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingUnderweight ➝ Underweight4/14/2025TLRYTilray BrandsRoth CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral4/9/2025TLRYTilray BrandsPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$2.00 ➝ $1.00(Data available from 6/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCGCCanopy Growth$225.65M0.99N/AN/A$1.90 per share0.64CRONCronos Group$117.61M6.26N/AN/A$2.90 per share0.66STDAFSTADA Arzneimittel Aktiengesellschaft$3.84B1.79$11.12 per share9.93$23.11 per share4.78TLRYTilray Brands$210.48M1.98N/AN/A$4.14 per share0.10USNAUSANA Health Sciences$854.50M0.67$3.71 per share8.25$27.92 per share1.10Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCGCCanopy Growth-$429.86M-$4.04N/AN/AN/A-195.76%-88.54%-40.78%8/8/2025 (Estimated)CRONCronos Group$41.08M$0.1314.6963.6732.3139.69%-0.07%-0.07%8/6/2025 (Estimated)STDAFSTADA Arzneimittel Aktiengesellschaft$292.15MN/A0.00∞N/AN/AN/AN/AN/ATLRYTilray Brands-$244.98M-$1.05N/AN/AN/A-113.85%-7.40%-6.02%8/4/2025 (Estimated)USNAUSANA Health Sciences$42.03M$1.8216.8010.580.993.98%8.94%6.74%7/22/2025 (Estimated)Latest CGC, TLRY, STDAF, CRON, and USNA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/22/2025Q2 2025USNAUSANA Health Sciences$0.54N/AN/AN/A$225.20 millionN/A5/30/2025Q4 2025CGCCanopy Growth-$0.28-$0.94-$0.66-$1.00$71.84 million$45.30 million5/8/2025Q1 2025CRONCronos Group$0.01$0.02+$0.01$0.02$45.44 million$33.62 million4/22/2025Q1 2025USNAUSANA Health Sciences$0.70$0.73+$0.03$0.49$243.08 million$249.54 million4/8/2025Q3 2025TLRYTilray Brands-$0.04-$0.10-$0.06-$0.87$213.38 million$185.78 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCGCCanopy GrowthN/AN/AN/AN/AN/ACRONCronos GroupN/AN/AN/AN/AN/ASTDAFSTADA Arzneimittel AktiengesellschaftN/AN/AN/AN/AN/ATLRYTilray BrandsN/AN/AN/AN/AN/AUSNAUSANA Health SciencesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCGCCanopy Growth0.623.122.10CRONCronos GroupN/A27.8026.75STDAFSTADA Arzneimittel Aktiengesellschaft2.231.540.99TLRYTilray Brands0.122.621.61USNAUSANA Health SciencesN/A2.051.51Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCGCCanopy Growth3.33%CRONCronos Group8.71%STDAFSTADA Arzneimittel AktiengesellschaftN/ATLRYTilray Brands9.35%USNAUSANA Health Sciences54.25%Insider OwnershipCompanyInsider OwnershipCGCCanopy Growth1.30%CRONCronos Group6.90%STDAFSTADA Arzneimittel AktiengesellschaftN/ATLRYTilray Brands0.60%USNAUSANA Health Sciences0.63%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCGCCanopy Growth3,150183.87 million181.48 millionOptionableCRONCronos Group450385.68 million359.07 millionOptionableSTDAFSTADA Arzneimittel Aktiengesellschaft12,50062.34 millionN/ANot OptionableTLRYTilray Brands2,6501.01 billion1.00 billionOptionableUSNAUSANA Health Sciences1,70018.62 million18.51 millionOptionableCGC, TLRY, STDAF, CRON, and USNA HeadlinesRecent News About These CompaniesGAMMA Investing LLC Has $225,000 Holdings in USANA Health Sciences, Inc. (NYSE:USNA)June 22, 2025 | marketbeat.comRhumbline Advisers Has $979,000 Stake in USANA Health Sciences, Inc. (NYSE:USNA)June 20, 2025 | marketbeat.comUSNA vs. STVN: Which Stock Is the Better Value Option?June 18, 2025 | zacks.comUSANA Health (USNA) Upgraded to Buy: Here's What You Should KnowJune 17, 2025 | zacks.comIs USANA Health Sciences (USNA) Stock Undervalued Right Now?June 17, 2025 | zacks.com5 Low Price-to-Book Value Stocks That You Can Buy in JuneJune 17, 2025 | zacks.comUSANA Health Sciences, Inc. (NYSE:USNA) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?June 17, 2025 | finance.yahoo.comUSANA CEO Elected to Board of Direct Selling AssociationJune 17, 2025 | prnewswire.comUSANA Takes Home Five Best of State Awards, Including the Coveted Best of State StatueJune 12, 2025 | prnewswire.comUSANA Health Sciences, Inc. (NYSE:USNA) Director Sells $14,830.00 in StockJune 10, 2025 | marketbeat.comMillennium Management LLC Makes New Investment in USANA Health Sciences, Inc. (NYSE:USNA)June 8, 2025 | marketbeat.comReflecting On Personal Care Stocks’ Q1 Earnings: USANA (NYSE:USNA)June 4, 2025 | msn.comUSANA Executive Chairman Kevin Guest Celebrates National Outdoors Month with a Call to ...June 2, 2025 | gurufocus.comUSANA Executive Chairman Kevin Guest Celebrates National Outdoors Month with a Call to Reconnect with NatureJune 2, 2025 | prnewswire.comUSANA Health Sciences, Inc. (NYSE:USNA) COO Walter Noot Sells 6,291 SharesMay 30, 2025 | marketbeat.comAmeriprise Financial Inc. Has $2.75 Million Stock Position in USANA Health Sciences, Inc. (NYSE:USNA)May 30, 2025 | marketbeat.comShareholders in USANA Health Sciences (NYSE:USNA) are in the red if they invested five years agoMay 21, 2025 | finance.yahoo.comUSANA Health Sciences, Inc. (NYSE:USNA) CFO Sells $134,666.28 in StockMay 13, 2025 | insidertrades.comUSNA Q1 Earnings Call: Product Expansion and Market Momentum Drive OutperformanceMay 13, 2025 | finance.yahoo.comUSANA Releases 2024 Sustainability ReportMay 8, 2025 | prnewswire.comKevin Guest Shares Transformative Success Strategies on Executive Coaching Day, May 1May 1, 2025 | prnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBigBear.ai Poised to Benefit as Palantir Dominates AI DefenseBy Gabriel Osorio-Mazilli | June 23, 2025View BigBear.ai Poised to Benefit as Palantir Dominates AI DefenseIntel's Turnaround Strategy Shifts From Planning to Attack ModeBy Jeffrey Neal Johnson | June 20, 2025View Intel's Turnaround Strategy Shifts From Planning to Attack ModeMicron: A Hot Buy Heats Up, Fresh All-Time Highs Are ComingBy Thomas Hughes | June 26, 2025View Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are ComingMicron Joins Latest $200 Billion United States Investment By Gabriel Osorio-Mazilli | June 16, 2025View Micron Joins Latest $200 Billion United States Investment CGC, TLRY, STDAF, CRON, and USNA Company DescriptionsCanopy Growth NASDAQ:CGC$1.22 0.00 (0.00%) As of 04:00 PM EasternCanopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments. The company offers dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles comprising gummies, and topical formats, as well as vaporizer devices. It sells its products under the Tweed, 7ACRES, DOJA, Deep Space, HiWay, Maitri, Twd., Vert, Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Martha Stewart, and Wana brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.Cronos Group NASDAQ:CRON$1.91 +0.01 (+0.53%) As of 04:00 PM EasternCronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.STADA Arzneimittel Aktiengesellschaft OTCMKTS:STDAF$110.42 0.00 (0.00%) As of 10/24/2022STADA is a publicly traded, international company with a focus on the healthcare market, especially the pharmaceutical and in particular the generics market.Tilray Brands NASDAQ:TLRY$0.41 +0.01 (+3.42%) As of 04:00 PM EasternTilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.USANA Health Sciences NYSE:USNA$30.58 -0.55 (-1.77%) As of 03:58 PM EasternUSANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Tesla’s Robotaxi Hype Fuels Bullish Price Targets to $500 S&P 500 All-Time Highs: 5 Catalysts Driving It Higher The Top Insider Sells From Q2: Buy, Sell, or Hold? 5 High-Yielding ETFs to Buy and Hold Forever Why BigBear.ai Could Rally 100% and Catch Palantir Soon Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Alphabet’s Waymo and Services Beginning to Feel the Pressure? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
